These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37000124)

  • 41. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism.
    Yu SY; Sun L; Liu Z; Huang XY; Zuo LJ; Cao CJ; Zhang W; Wang XM
    PLoS One; 2013; 8(12):e82924. PubMed ID: 24376607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron metabolism and the risk of restless legs syndrome in an elderly general population--the MEMO-Study.
    Berger K; von Eckardstein A; Trenkwalder C; Rothdach A; Junker R; Weiland SK
    J Neurol; 2002 Sep; 249(9):1195-9. PubMed ID: 12242538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease.
    Sun J; Martin JM; Vanderpoel V; Sumbria RK
    Neuromolecular Med; 2019 Mar; 21(1):12-24. PubMed ID: 30656553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron transport kinetics through blood-brain barrier endothelial cells.
    Khan AI; Liu J; Dutta P
    Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1168-1179. PubMed ID: 29466707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
    Farr AC; Xiong MP
    Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ironing out the Brain.
    Ward RJ; Crichton RR
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders.
    Bañuelos-Cabrera I; Valle-Dorado MG; Aldana BI; Orozco-Suárez SA; Rocha L
    Arch Med Res; 2014 Nov; 45(8):677-86. PubMed ID: 25446620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.
    Connor JR; Menzies SL; St Martin SM; Mufson EJ
    J Neurosci Res; 1992 Jan; 31(1):75-83. PubMed ID: 1613823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.
    Trenkwalder C; Winkelmann J; Oertel W; Virgin G; Roubert B; Mezzacasa A;
    Mov Disord; 2017 Oct; 32(10):1478-1482. PubMed ID: 28643901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.
    McCarthy RC; Kosman DJ
    Cell Mol Life Sci; 2015 Feb; 72(4):709-27. PubMed ID: 25355056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
    Du F; Qian ZM; Luo Q; Yung WH; Ke Y
    Mol Neurobiol; 2015 Aug; 52(1):101-14. PubMed ID: 25115800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Piñero DJ; Hu J; Connor JR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.
    Raha AA; Vaishnav RA; Friedland RP; Bomford A; Raha-Chowdhury R
    Acta Neuropathol Commun; 2013 Sep; 1():55. PubMed ID: 24252754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier.
    Moroo I; Ujiie M; Walker BL; Tiong JW; Vitalis TZ; Karkan D; Gabathuler R; Moise AR; Jefferies WA
    Microcirculation; 2003 Dec; 10(6):457-62. PubMed ID: 14745458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory mechanisms for iron transport across the blood-brain barrier.
    Duck KA; Simpson IA; Connor JR
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):70-75. PubMed ID: 29054412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolism of neuronal iron and its pathogenic role in neurological disease: review.
    Moos T; Morgan EH
    Ann N Y Acad Sci; 2004 Mar; 1012():14-26. PubMed ID: 15105252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?
    Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL
    J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.